Trends in Neurosciences
The macro- and microarchitectures of the ligand-binding domain of glutamate receptors
Section snippets
Primary structure similarities between GluRs and distantly related proteins
Detailed amino acid sequence comparisons followed by multiple alignments of mGluRs and iGluRs with various bacterial periplasmic binding proteins (PBPs) led Nakanishi et al.[31] and O'Hara et al.[32] to recognize that several regions of amino acid sequence similarities exist between these protein families. Thus, it was proposed that: (1) the first ∼ 400 amino acids of mGluRs and iGluRs share a common folding pattern with the bacterial periplasmic leucine/isoleucine/ valine-binding protein
Deciphering the transmembrane-subunit topology of iGluRs
Based on hydrophobicity plots, at the time they were cloned each subunit of an oligomeric iGluR was considered to weave through the cell membrane four times, thus adopting the transmembrane topology that is typical of acetylcholine-, glycine- and γ-aminobutyric acid (GABA)-gated channels[8]. Such a topological organization placed the amino terminal domain (ATD) and the carboxyl-terminus region of an iGluR subunit (see Fig. 1A for definitions) facing the extracellular space where they could be
The regions that create the Glu-binding domain
Further work by Heinemann and his colleagues shed light on the relevance of the novel topology to the Glu-binding domain by showing that both segments, S1 and S2 (that were first defined by these researchers), determine the pharmacological specificity of AMPA–KA receptor chimeras (iGluR3-iGluR6 chimeras)[49]. For example, whereas AMPA does not bind and elicit currents in Xenopus oocytes expressing iGluR6, the simultaneous replacement of S1 and S2 segments by those of iGluR3 resulted in a
The modelled structure of the ligand-binding site of iGluRs
Attracted by the idea that S1 and S2 might share a similar folding pattern with PBPs, several groups have undertaken to identify residues involved in ligand binding to iGluRs.
Efficient activation of the NMDA receptor channel requires co-assembly of NR1 and NR2 subunits as well as simultaneous binding of both Glu and the co-agonist glycine (Gly)[8]. Because NR1 has a glycine-binding motif, FXY, and amino acid sequence similarities with LAOBP, extensive site-directed mutagenesis followed by
Ionotropic GluRs are allosteric proteins
In the case of allosteric regulation, conformational changes cause coupling of two spatially separated regulatory (such as a ligand-binding site) and active (such as a channel pore) sites. Hence, iGluRs could be viewed as allosteric integral-membrane proteins. Moreover, the activation of iGluRs by various agonists, including activation of the NMDAR by Gly, produce sigmoid (that is, co-operative) dose-response curves that exhibit Hill coefficient values of 1.2–2.2 (depending on the agonist type
A plausible model for the allosteric transitions of iGluRs
(1) The model includes four interacting subunits each possessing a LAOBP-like binding domain for glutamatergic ligands. In cases of homomeric assembly of AMPA or KA receptors, the receptor oligomer would be composed of four subunits carrying identical ligand-binding domains. The NMDA receptor complex would consist of two NR2 Glu-binding subunits and two NR1 Gly-binding subunits.
(2) In the absence of effectors, the four ligand-binding domains would simultaneously undergo transitions between an
Experimental support for the existence of the various allosteric states
As in the case of nearly all signal transduction systems, a rapid turnoff is characteristic of ligand-gated ion channels. After a short period of activation (ion permeation) the liganded receptor undergoes desensitization, that is, exhibits a closed-channel conformation and transiently becomes refractory to re- activation. Mano et al.[56] described mutations that impaired the ability of Glu and Quis to desensitize iGluR1 channels and to inhibit the currents evoked by the weakly desensitizing
The f lip/f lop segment of AMPA receptors might couple movements of the ligand-binding lobes to channel regions
The flip/flop region located upstream from M4 of AMPA receptors belongs, in terms of the primary structure, to the S2 region (Fig. 1B). Structural models49, 54, 55, 83 (Fig. 3) reveal that the segment homologous to the flip/flop region of AMPA receptors comes after the second hinge region that crosses from lobe II back to lobe I. This segment is not located in the vicinity of the interlobe cleft but forms a long, kinked α helix at the back of the molecule while forming contacts with components
Antibodies that mimic the action of glutamatergic agonists
Rabbits immunized with the ATD of iGluR3 develop high titres of anti-iGluR3 antibodies and symptoms reminiscent of those that appear in patients with Rasmussen's encephalitis[86], a progressive, rare childhood disease characterized by severe epilepsy, hemiplegia, dementia and inflammation of the brain[87]. Serum sampled from individuals who have this progressive disease was found to immunoreact against denatured and native iGluR3, but not against iGluR1, 2, 5 and 6, suggesting that Rasmussen's
Perspectives
In the absence of X-ray crystallographic data, the available model structures and future models of other iGluR subunits would probably provide a practical target for drug design. The finding of novel binding ligands might not only validate the structural models, assist with the refinement of their co-ordinates and lead to a better understanding of how channel activity is coupled to extracellular domain movements, but might also result in revealing compounds that are able to modify the activity
Note added in proof
At the time the current review article was in press, Swanson et al.[83] published results that demonstrate the involvement of two amino acids in the specific responses of the KA receptors iGluR5 and iGluR6 to different agonists. These two residues align with KA-binding residues located in the putative lobe II of cKBP. As has been noted by Swanson et al., their results validate the cKBP model structure (Fig. 3) as a useful construct for modelling the structure of the ligand-binding domain of
Acknowledgements
I wish to thank Jean-Pierre Changeux for critically reading the manuscript, stimulating discussion and his unfailing support; Lisa Marubio, Anne Devillers-Thiéry and Stuart J. Edelstein for critical reading of the manuscript and Pierre-Jean Corringer, Clément Léna and Vivian I. Teichberg for their judicious advice. This work was supported by long-term fellowships from the Federation of European Biochemical Societies and the Human Frontier Science Program Organization.
References (90)
- et al.
Neuropharmacology
(1995) J. Biol. Chem.
(1992)Trends Pharmacol. Sci.
(1997)J. Biol. Chem.
(1994)J. Biol. Chem.
(1994)Trends Neurosci.
(1993)Neuron
(1996)- et al.
Neuron
(1994) - et al.
Brain Res. Rev.
(1990) - et al.
Trends Neurosci.
(1988)
Neuron
Trends Pharmacol. Sci.
Neuron
Neuron
Neuron
J. Biol. Chem.
Neuron
Neuron
J. Biol. Chem.
Neuron
Neuropharmacology
J. Biol. Chem.
Neuron
Neuron
Biophys. J.
J. Biol. Chem.
Neuron
Eur. J. Pharmacol.
Eur. J. Pharmacol.
Brain Res.
Neurochem. Int.
FEBS Lett.
J. Biol. Chem.
J. Mol. Biol.
J. Mol. Biol.
Neuron
J. Biol. Chem.
Neuron
Neuron
Neuron,
J. Biol. Chem.
J. Neurochem.
Proc. Natl. Acad. Sci. U. S. A.
Biochem J.
Cited by (89)
Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site
2013, Journal of Biological ChemistryCitation Excerpt :The LBD of each subunit is composed of two segments of the protein (S1 and S2) and contains the agonist-binding site. The S1 and S2 segments together form a bilobed, clamshell-like structure, with the two subdomains (D1 and D2) representing the upper and the lower lobes, respectively (11–14). Numerous glycine site antagonists have been identified that can be categorized into different classes according to their chemical structure.
Structure-function correlates of glutamate-gated ion channels
2012, Comprehensive BiophysicsCharacterizing single-channel behavior of GluA3 receptors
2010, Biophysical JournalCitation Excerpt :Each subunit has an LBD that is capable of binding one agonist molecule, a transmembrane domain that is responsible for channel gating, an extracellular N-terminal domain, and an intracellular C-terminal domain (1,2,11). Glutamate binding to the LBD leads to opening of the ion channel and a positive inward current, consisting of Na+, K+, and, depending on subunit composition and RNA editing (12), Ca2+ (13–15). The rate of desensitization is determined in part by a short sequence in the LBD called the flip/flop region (16); the flop form desensitizes faster than the flip form (17,18).
Influence of the NR3A subunit on NMDA receptor functions
2010, Progress in NeurobiologyCitation Excerpt :As with other NMDAR subunits, the NR3A amino acid sequence encodes an extracellular bi-lobed domain (split into S1 and S2 segments by membrane domains TM1, TM2, and TM3) that determines ligand-binding specificity. But unlike NR2 subunits, which bind glutamate, the S1 region of the extracellular N-terminus and the S2 region of the extracellular loop between TM3 and TM4 form a glycine binding pocket, a clamshell-like structure (Paas, 1998; Yao et al., 2008; Yao and Mayer, 2006). Additionally, the second membrane pore loop (TM2) and the third membrane pore loop (TM3) in both NR3A and NR3B are substantially different from other NMDAR subunits.
Improving solubility of NR2B amino-terminal domain of N-methyl-d-aspartate receptor expressed in Escherichia coli
2007, Biochemical and Biophysical Research CommunicationsOn the role of NR3A in human NMDA receptors
2007, Physiology and Behavior